ArticlePulmonary therapy2026

Clinical Outcomes in Concurrent Cohorts of Elexacaftor/Tezacaftor/Ivacaftor (ELX/TEZ/IVA)-Treated versus ELX/TEZ/IVA-Ineligible Individuals with Cystic Fibrosis in the US during COVID-19.

Christian A Merlo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.